Skip to main content
. 2025 Aug 15;104(33):e41868. doi: 10.1097/MD.0000000000041868

Table 3.

Comparing screening tools.

Tool Pros Cons Costs Special features
COVIDENCE[32] Efficient automation for title and abstract screening. Supports collaborative screening and data extraction. High cost relative to other tools. Limited to 5 reviewers on the basic plan. $289 USD/yr (basic plan). Additional fees for more users or features. Provides bulk upload of references, integrates with citation managers like EndNote, and offers conflict resolution tools for reviewers.
Rayyan[44] Highly sensitive and specific for title screening in systematic reviews. User-friendly interface. Free version is limited to small projects; full functionality requires a paid subscription. Some features, like advanced collaboration tools and full integration with reference managers, are only available in the paid version. Free for basic use; pricing starts at $100/yr for premium features. Utilizes AI-driven text mining methods for semiautomated screening. Allows for blinding and unblinding of reviewer decisions, and offers tagging and coding options.
Abstrackr[46] Facilitates semiautomated abstract screening with a user-friendly interface. Provides objective scoring in reviewer assessment. Limited functions: lacks full-text screening, citation management integration, and advanced reporting features. Free Uses predictive modeling to suggest the relevance of abstracts. Can be used for collaborative reviews, though it may require more manual effort for conflict resolution.
ASReview[47] Uses active learning to prioritize records for review, improving efficiency in identifying relevant studies. Limited features beyond screening, such as no built-in citation management or advanced data extraction tools. Free, Open-source software. Incorporates machine learning algorithms for iterative screening, which adapts based on reviewer input to improve the relevance of subsequent records.
JBI SUMARI[33] Offers an intuitive and aesthetically pleasing dashboard, guiding users through each stage of the systematic review process with large clickable buttons and fillable boxes. The software does not support title and abstract screening, also does not allow for the upload of full-text studies, focusing instead on final reviews. $130 USD per annum. First-time users can access a 14-d free trial to evaluate the software’s features JBI SUMARI supports 3 different types of data synthesis, simplifying the creation of forest plots and meta-aggregative flowcharts.